Literature DB >> 22183820

Prevalence of hypothyroidism in nonalcoholic fatty liver disease.

Mangesh R Pagadala1, Claudia O Zein, Srinivasan Dasarathy, Lisa M Yerian, Rocio Lopez, Arthur J McCullough.   

Abstract

BACKGROUND: A possible association between nonalcoholic fatty liver disease (NAFLD) and hypothyroidism has been suggested. The recognized link between hypothyroidism and elements of the metabolic syndrome may explain this association. AIM: The purpose of this study was to determine the prevalence of hypothyroidism in a cohort of patients with NAFLD and analyze the potential factors associated with hypothyroidism in this patient population.
METHODS: Two hundred forty-six patients with biopsy-proven NAFLD attending hepatology clinics at the Cleveland Clinic between October 2006 and June 2009, and 430 age-, gender-, race- and BMI-matched control subjects seen in the general internal medicine clinic were included. Patients with a clinical diagnosis of hypothyroidism who were on thyroid replacement therapy were considered to be hypothyroid.
RESULTS: Hypothyroidism was more frequent among patients with NAFLD (21% vs. 9.5%; P < 0.01) compared to controls, and was higher in NASH patients than NAFLD patients without NASH (25% vs. 12.8%, P = 0.03). Subjects with hypothyroidism were 2.1 (95% CI 1.1-3.9, P = 0.02) and 3.8 (95% CI 2-6.9, P < 0.001) times more likely to have NAFLD and NASH, respectively. By multivariate analysis, female gender (P < 0.001) and increased BMI (P = 0.03) were associated with hypothyroidism. NAFLD subjects who reported mild alcohol consumption were less likely to have hypothyroidism compared to those who reported complete abstinence (OR 0.37, P = 0.008).
CONCLUSIONS: A higher prevalence of hypothyroidism was demonstrated in patients with NAFLD compared to controls. Among subjects with NALFD, female gender, increased BMI and history of abstinence from alcohol were associated with hypothyroidism. Patients with hypothyroidism were also more likely to have NASH.

Entities:  

Mesh:

Year:  2011        PMID: 22183820      PMCID: PMC3922233          DOI: 10.1007/s10620-011-2006-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  The metabolic actions of thyroid hormone and leptin: a mandatory interplay or not?

Authors:  R Vettor
Journal:  Diabetologia       Date:  2005-03-12       Impact factor: 10.122

2.  Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

Authors:  Frederico G S Toledo; Allan D Sniderman; David E Kelley
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

Review 3.  Thyroid hormones and treatment of obesity.

Authors:  M Krotkiewski
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

4.  Subclinical hypothyroidism affects mitochondrial function.

Authors:  J Kvetny; L Wilms; P L Pedersen; J Larsen
Journal:  Horm Metab Res       Date:  2010-02-22       Impact factor: 2.936

5.  Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT).

Authors:  T Bjoro; J Holmen; O Krüger; K Midthjell; K Hunstad; T Schreiner; L Sandnes; H Brochmann
Journal:  Eur J Endocrinol       Date:  2000-11       Impact factor: 6.664

6.  Insulin action in adipose tissue and muscle in hypothyroidism.

Authors:  George Dimitriadis; Panayota Mitrou; Vaia Lambadiari; Eleni Boutati; Eirini Maratou; Demosthenes B Panagiotakos; Efi Koukkou; Marinela Tzanela; Nikos Thalassinos; Sotirios A Raptis
Journal:  J Clin Endocrinol Metab       Date:  2006-09-26       Impact factor: 5.958

7.  Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

Authors:  Edward E Cable; Patricia D Finn; Jeffrey W Stebbins; Jinzhao Hou; Bruce R Ito; Paul D van Poelje; David L Linemeyer; Mark D Erion
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Thyroid function in humans with morbid obesity.

Authors:  Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou
Journal:  Thyroid       Date:  2006-01       Impact factor: 6.568

9.  Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index.

Authors:  Nivedita Nanda; Zachariah Bobby; Abdoul Hamide; Bidhan Chandra Koner; Magadi Gopalakrishna Sridhar
Journal:  Metabolism       Date:  2007-10       Impact factor: 8.694

10.  Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: a cross-sectional study from South India.

Authors:  Ghanshyam Palamaner Subash Shantha; Anita A Kumar; Vijay Jeyachandran; Deepan Rajamanickam; K Rajkumar; Shihas Salim; Kuyilan Karai Subramanian; Senthilkumar Natesan
Journal:  Thyroid Res       Date:  2009-03-09
View more
  52 in total

1.  Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India.

Authors:  Pathik Parikh; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2015-04-16

Review 2.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

3.  Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.

Authors:  Paul Manka; Lars Bechmann; Jan Best; Svenja Sydor; Lee C Claridge; Jason D Coombes; Ali Canbay; Lars Moeller; Guido Gerken; Heiner Wedemeyer; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2019-06-03       Impact factor: 3.199

4.  Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.

Authors:  Alessandro Mantovani; Giorgio Grani
Journal:  Dig Dis Sci       Date:  2018-04-19       Impact factor: 3.199

5.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 6.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue.

Authors:  Wilhelmus J Kwanten; Wim Martinet; Peter P Michielsen; Sven M Francque
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.

Authors:  Kil Woo Lee; Ki Bae Bang; Eun Jung Rhee; Heon Ju Kwon; Mi Yeon Lee; Yong Kyun Cho
Journal:  Clin Mol Hepatol       Date:  2015-12-24

Review 9.  Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.

Authors:  Ahad Eshraghian; Alireza Hamidian Jahromi
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms.

Authors:  Giuseppe Ferrandino; Rachel R Kaspari; Olga Spadaro; Andrea Reyna-Neyra; Rachel J Perry; Rebecca Cardone; Richard G Kibbey; Gerald I Shulman; Vishwa Deep Dixit; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.